QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
QQQ   349.08 (+0.20%)
AAPL   177.00 (+0.89%)
MSFT   331.35 (-0.46%)
META   261.81 (-0.09%)
GOOGL   122.79 (-1.46%)
AMZN   121.11 (+0.83%)
TSLA   198.58 (+2.80%)
NVDA   400.70 (+2.89%)
NIO   7.40 (-3.90%)
BABA   78.23 (-3.38%)
AMD   125.51 (-1.20%)
T   15.64 (+0.90%)
F   12.61 (+4.30%)
MU   71.87 (-2.79%)
CGC   0.86 (-1.98%)
GE   101.80 (-0.91%)
DIS   87.24 (-1.19%)
AMC   4.57 (-1.51%)
PFE   37.10 (-1.33%)
PYPL   61.51 (+2.14%)
NFLX   389.53 (+2.81%)
CVE:LTY

Liberty Biopharma (LTY) Stock Forecast, Price & News

C$2.00
+2.00 (+∞)
(As of 10/10/2018)
Compare
Today's Range
C$2.00
C$2.00
50-Day Range
C$2.00
C$2.00
52-Week Range
C$0.06
C$2.74
Volume
700 shs
Average Volume
23,286 shs
Market Capitalization
C$21.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

LTY stock logo

About Liberty Biopharma (CVE:LTY) Stock

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LTY Stock News Headlines

Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
Intech Biopharm Ltd (6461)
Liberty Defense Holdings Ltd (LDDFF)
Lepu Biopharma Co Ltd (2157)
Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
YS BIOPHARMA CO LTD
Liberty Home Guard Review 2023
Guide to Visiting the Statue of Liberty
See More Headlines
Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Book Value
C$0.79 per share

Miscellaneous

Free Float
N/A
Market Cap
C$21.54 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Norman Tsui (Age 45)
    Pres, CEO & Director
  • Mr. Shui Yan Tam (Age 44)
    Chief Financial Officer
  • Dr. Michael T. McNamara
    Medical Advisor & Director
  • Dr. Richard Huang Ph.D. (Age 42)
    Chief Technology Officer
  • Dr. Richard Cook M.D.
    Msc., FRCSC, Chief Medical Officer













LTY Stock - Frequently Asked Questions

How have LTY shares performed in 2023?

Liberty Biopharma's stock was trading at C$2.00 at the beginning of the year. Since then, LTY stock has increased by 0.0% and is now trading at C$2.00.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Liberty Biopharma own?
What is Liberty Biopharma's stock symbol?

Liberty Biopharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LTY."

How do I buy shares of Liberty Biopharma?

Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Liberty Biopharma's stock price today?

One share of LTY stock can currently be purchased for approximately C$2.00.

How much money does Liberty Biopharma make?

Liberty Biopharma (CVE:LTY) has a market capitalization of C$21.54 million.

How can I contact Liberty Biopharma?

Liberty Biopharma's mailing address is 2270-8788 McKim Way, RICHMOND, BC V6X 4E2, Canada. The official website for the company is www.libertybiopharma.com. The biotechnology company can be reached via phone at +1-604-3777575.

This page (CVE:LTY) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -